Bluejay Diagnostics, Inc. 8-K

What Happened

• Bluejay Diagnostics, Inc. filed a Form 8-K (filed Feb 18, 2026) to disclose a press release dated February 17, 2026 announcing an update on its clinical study enrollment and manufacturing readiness initiatives. The disclosure was made under Regulation FD and the press release is furnished as Exhibit 99.1.

Key Details

• Filing: Form 8-K filed February 18, 2026 (Regulation FD disclosure, Item 7.01).
• Press release date: February 17, 2026; furnished as Exhibit 99.1 to the 8-K.
• Topics disclosed: progress on clinical study enrollment and on manufacturing readiness initiatives.
• The 8-K did not present earnings, financial statements, or executive changes.

Why It Matters

• Operational updates on clinical enrollment and manufacturing readiness are material operational milestones investors track because they relate to a company's ability to advance trials and scale production.
• By using Regulation FD (Item 7.01) and furnishing the press release, Bluejay is making the information broadly available to all investors at the same time, improving disclosure transparency.
• The filing does not include financial results or forward-looking financial metrics; investors should look for future filings or company communications for timing, financial impact, or regulatory outcomes.